Locations:
Search
Findings expand upon earlier data, providing new noninvasive options
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment
Management of high-risk RMSK in the pre-and current eras of neoadjuvant therapy
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The multidisciplinary research team reported their findings in JAMA
Physicians explain findings from a recent study
Study reviews institutional experience
New grant will fund work to map human bladder and ureter at a cellular and molecular level
First in-human-trial for diagnostic bladder disorder device
Considerations to help guide patients through the decision-making process
Advertisement
Advertisement